Pfizer to build $465m injectable medicines facility in US

Pfizer has revealed plans to invest $465m for the construction of an advanced sterile injectable pharmaceutical manufacturing plant at Portage in Michigan, US.

The multi-storey, 400,000ft2 Modular Aseptic Processing (MAP) facility is intended to bolster the company’s production and supply capacity.

MAP will feature advanced aseptic manufacturing equipment, systems and design. It will be equipped with multiple, self-contained modular manufacturing lines.

Pfizer chairman and CEO Ian Read said: "This investment is part of our overall plan announced in January to invest approximately $5bn in US-based capital projects as a result of the enactment of the Tax Cuts and Jobs Act.

"Every day, we strive to enhance our ability to bring medicines to the patients who need them, and the new facility we are building in Michigan will help us continue to deliver therapies that significantly improve people’s lives."

Over the next several years, the new production facility is expected to create approximately 450 jobs in Portage where the company currently employs over 2,200 people at another site.

-----------------------------------------------------------------------------------------------------------------------------------------------

Editor's Note:

To apply for becoming a contributor of en-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.